BETA Stock Chart & Stats
₹2194.20
-₹84.90(-3.67%)
At close: 4:00 PM EDT
₹2194.20
-₹84.90(-3.67%)
Day’s Range― - ―
52-Week Range₹990.10 - ₹2,807.90
Previous CloseN/A
Volume29.57K
Average Volume (3M)3.15K
Market Cap
₹25.07B
Enterprise Value₹18.60K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)49.6
Beta0.75
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)14.78
Shares Outstanding11,085,872
10 Day Avg. Volume3,423
30 Day Avg. Volume3,150
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)67
Revenue Forecast (FY)₹5.21B
Beta Drugs Ltd. News
BETA FAQ
What was Beta Drugs Ltd.’s price range in the past 12 months?
Beta Drugs Ltd. lowest stock price was ₹990.10 and its highest was ₹2807.90 in the past 12 months.
What is Beta Drugs Ltd.’s market cap?
Beta Drugs Ltd.’s market cap is ₹25.07B.
When is Beta Drugs Ltd.’s upcoming earnings report date?
Beta Drugs Ltd.’s upcoming earnings report date is Nov 11, 2026 which is in 75 days.
How were Beta Drugs Ltd.’s earnings last quarter?
Beta Drugs Ltd. released its earnings results on Jul 20, 2026. The company reported ₹14.78 earnings per share for the quarter, beating the consensus estimate of N/A by ₹14.78.
Is Beta Drugs Ltd. overvalued?
According to Wall Street analysts Beta Drugs Ltd.’s price is currently Overvalued.
Does Beta Drugs Ltd. pay dividends?
Beta Drugs Ltd. does not currently pay dividends.
What is Beta Drugs Ltd.’s EPS estimate?
Beta Drugs Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beta Drugs Ltd. have?
Beta Drugs Ltd. has 11,085,872 shares outstanding.
What happened to Beta Drugs Ltd.’s price movement after its last earnings report?
Beta Drugs Ltd. reported an EPS of ₹14.78 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 9.434%.
Which hedge fund is a major shareholder of Beta Drugs Ltd.?
Currently, no hedge funds are holding shares in IN:BETA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
Alembic Limited
―
Indoco Remedies Limited
―
Ind-Swift Laboratories Ltd.
―
Mukand Limited
―
Sai Parenterals Limited
―